TNF-alpha associated with fibronectin enhances phorbol myristate acetate- or antigen-mediated integrin-dependent adhesion of CD4+ T cells via protein tyrosine phosphorylation. [PDF]
, 1994 Rami Hershkoviz +7 more
openalex +1 more source
Advanced Therapeutics, EarlyView.Emerging microphysiological systems reproduce the spatial, biochemical, and cellular complexity of the tumor microenvironment, surpassing 2D cultures and murine models. By integrating patient‐derived tumors, perfusable vasculature, and immune trafficking, these organ‐on‐chip platforms reveal mechanisms of immune evasion, predict therapeutic responses ...
Fabiana Moresi +5 more
wiley +1 more source
The Serine/Threonine Kinase NDR2 Regulates Integrin Signaling, Synapse Formation, and Synaptic Plasticity in the Hippocampus. [PDF]
J Neurochemdel Angel M +8 more
europepmc +1 more source
The role of 67 kDa laminin receptor in G-CSF-induced hematopoietic stem cell mobilization [PDF]
, 2007 Visconte, Valeria
core +1 more source
Complete amino acid sequence of an integrin beta subunit (beta 7) identified in leukocytes
, 1991 David J. Erle +3 more
openalex +1 more source
Central and peripheral neurite outgrowth differs in preference for heparin-binding versus integrin-binding sequences [PDF]
, 1992 PK Haugen +4 more
openalex +1 more source
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
Advanced Therapeutics, EarlyView.This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar +7 more
wiley +1 more source
Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications. [PDF]
Int J Mol SciKariya Y, Nishita M.
europepmc +1 more source
Genetic Engineering Methods in Primary T Cells
Advanced Therapeutics, EarlyView.Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley +1 more source
Extracellular PDI in thrombosis and vascular injury. [PDF]
Thromb JWang J, Hogg PJ, Xu X, Fang C.
europepmc +1 more source